Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.6740
-0.0300 (-4.26%)
Nov 6, 2026, 3:22 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 29.11 million as of November 6, 2026. It is the 45,199th most valuable company in the world and the 125th biggest in Denmark. Its market cap has decreased by 55.03% in one year.
Market Cap
29.11M
Enterprise Value
29.26M
Revenue
12.54M
Global Rank
Country Rank
#125 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 29.11M, a decrease of -91.09%. That is a compound annual growth rate of -31.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 29.11M | -54.46% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 213.80B |
| Coloplast | 117.72B |
| Demant | 79.17B |
| Gubra | 4.84B |
| BioPorto | 502.54M |
| Pharma Equity Group | 85.93M |
| Scandinavian Medical Solutions | 72.85M |